Miyake Goichiro, Ota Ichiro, Miyake Kensaku, Zako Masahiro, Iwaki Masayoshi, Shibuya Akihiko
From the Department of Ophthalmology (G. Miyake, Zako, Iwaki), Aichi Medical University, Aichi, the Shohzankai Medical Foundation (G. Miyake, Ota, K. Miyake), Miyake Eye Hospital, Nagoya, and Hoya Corporation Medical Division (Shibuya), Tokyo, Japan.
From the Department of Ophthalmology (G. Miyake, Zako, Iwaki), Aichi Medical University, Aichi, the Shohzankai Medical Foundation (G. Miyake, Ota, K. Miyake), Miyake Eye Hospital, Nagoya, and Hoya Corporation Medical Division (Shibuya), Tokyo, Japan.
J Cataract Refract Surg. 2015 Mar;41(3):666-9. doi: 10.1016/j.jcrs.2015.01.002. Epub 2015 Feb 14.
We describe 6 cases that developed intraocular inflammation between 42 days and 137 days after implantation of an acrylic foldable intraocular lens (IOL) (ISert model 251) and failed to respond to antibiotic treatment. One eye required a vitrectomy and IOL removal, 2 eyes required irrigation of the capsule, and 5 eyes required systemic administration of steroids. The healing process took 30 to 108 days after onset. Simultaneous with our cases was an epidemic outbreak of sterile anterior segment inflammation with the same characteristics associated with the same IOL. The clinical features indicated late-onset toxic anterior segment syndrome. Analysis of the outbreak strongly suggested that toxicity of the aluminum used in the IOL production process was the cause. This contamination risk exists even with modern manufacturing technology.
Mr. Shibuya is an employee of Hoya Corporation Medical Division. No other author has a financial or proprietary interest in any material or method mentioned.
我们描述了6例在植入丙烯酸可折叠人工晶状体(IOL)(ISert型号251)后42天至137天发生眼内炎症且对抗生素治疗无反应的病例。1只眼需要进行玻璃体切除术并取出人工晶状体,2只眼需要冲洗囊袋,5只眼需要全身使用类固醇。发病后愈合过程持续30至108天。与我们的病例同时发生的是一场具有相同特征的无菌性前段炎症的流行爆发,与同一种人工晶状体有关。临床特征表明为迟发性毒性前段综合征。对此次爆发的分析强烈提示,人工晶状体生产过程中使用的铝的毒性是病因。即使采用现代制造技术,这种污染风险依然存在。
Shibuya先生是Hoya公司医疗部门的员工。其他作者对文中提及的任何材料或方法均无财务或专利权益。